Biomater. Sci., 2025, Accepted Manuscript
DOI: 10.1039/D5BM00245A, Review Article
DOI: 10.1039/D5BM00245A, Review Article


Jiyu Jessica Tian, Hamid Ebrahimi Orimi, Natalie Fekete, Nicolas Drolet, Katie Campbell, Michel Tremblay, Linda Peltier, Pierre Laneuville, Pierre-Luc Girard-Lauriault, Corinne A Hoesli
Dendritic cell-based immunotherapy is a promising strategy to treat malignant diseases. In vitro manufacturing of dendritic cells conventionally relies on culturing primary monocytes in dishes or vessels made from tissue...
The content of this RSS Feed (c) The Royal Society of Chemistry
Dendritic cell-based immunotherapy is a promising strategy to treat malignant diseases. In vitro manufacturing of dendritic cells conventionally relies on culturing primary monocytes in dishes or vessels made from tissue...
The content of this RSS Feed (c) The Royal Society of Chemistry